Impact of neurofibromatosis type 1 with plexiform neurofibromas on the health-related quality of life and work productivity of adult patients and caregivers in the UK: a cross-sectional survey

BackgroundPlexiform neurofibromas (PN) are complex, benign nerve-sheath tumours that occur in 30-50% of patients with neurofibromatosis type 1 (NF1), a rare, genetic disorder. PN are associated with substantial, heterogeneous morbidities that impact health-related quality of life (HRQoL), including affecting motor function and causing pain, though HRQoL and work productivity data are scarce. This UK cross-sectional study explored HRQoL and work productivity in adult patients with NF1 PN and caregivers of paediatric patients.MethodsAdult patients and caregivers of paediatric patients self-enrolled in an online survey (March-April 2021). Outcomes included EQ-5D-5L, PROMIS (R) GH and INF1-QOL (adult patients only), and EQ-5D-5L, CarerQol and WPAI (caregivers only). Utilities were estimated from EQ-5D-5L responses using the UK crosswalk value set. Linear regression models explored univariable associations between adult patient characteristics and HRQoL.ResultsMean (+/- standard deviation) EQ-5D utility in adult patients with NF1 PN was 0.65 (+/- 0.29; n = 35; age-/sex-matched norm: 0.89 [+/- 0.04]). Moderate-extreme pain/discomfort and anxiety/depression were reported by 14/35 (40.0%) and 18/35 (51.4%) patients, respectively. Mean PROMIS (R) GH physical and mental health scores were 43.6 (+/- 9.19) and 41.7 (+/- 11.5; n = 35; matched norm: 50.0 [+/- 10.0]). Mean INF1-QOL score was 11.03 (+/- 6.02; n = 33). Chronic itching, at least one symptom, at least one comorbidity, PN location at extremities (arms/legs) and pain were associated with worse HRQoL scores.Mean caregiver EQ-5D utility was 0.72 (+/- 0.24; n = 8; age-/sex-matched norm: 0.88 [+/- 0.03]). Moderate pain/discomfort and moderate-severe anxiety/depression were reported by 4/8 (50.0%) and 2/8 (25.0%) caregivers, respectively. Mean CarerQol score was 69.3 (+/- 13.9; n = 8). Mean WPAI regular activity productivity loss was 36.3% (+/- 31.6%; n = 8).ResultsMean (+/- standard deviation) EQ-5D utility in adult patients with NF1 PN was 0.65 (+/- 0.29; n = 35; age-/sex-matched norm: 0.89 [+/- 0.04]). Moderate-extreme pain/discomfort and anxiety/depression were reported by 14/35 (40.0%) and 18/35 (51.4%) patients, respectively. Mean PROMIS (R) GH physical and mental health scores were 43.6 (+/- 9.19) and 41.7 (+/- 11.5; n = 35; matched norm: 50.0 [+/- 10.0]). Mean INF1-QOL score was 11.03 (+/- 6.02; n = 33). Chronic itching, at least one symptom, at least one comorbidity, PN location at extremities (arms/legs) and pain were associated with worse HRQoL scores.Mean caregiver EQ-5D utility was 0.72 (+/- 0.24; n = 8; age-/sex-matched norm: 0.88 [+/- 0.03]). Moderate pain/discomfort and moderate-severe anxiety/depression were reported by 4/8 (50.0%) and 2/8 (25.0%) caregivers, respectively. Mean CarerQol score was 69.3 (+/- 13.9; n = 8). Mean WPAI regular activity productivity loss was 36.3% (+/- 31.6%; n = 8).ConclusionsNF1 PN worsens adult patient and caregiver HRQoL compared to the general population, notably affecting pain and discomfort, anxiety and depression and caregiver productivity.